NASDAQ:PHVS

Pharvaris B.V. News Headlines

$23.08
-2.93 (-11.26 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.03
Now: $23.08▼
$26.60
50-Day Range
$25.69
MA: $29.90▼
$39.23
52-Week Range
$23.03
Now: $23.08▼
$42.86
Volume43,148 shs
Average Volume112,007 shs
Market Capitalization$734.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Pharvaris B.V. (NASDAQ PHVS) News Headlines Today

SourceHeadline
Pharvaris B.V. (NASDAQ:PHVS) Shares Down 10% Pharvaris B.V. (NASDAQ:PHVS) Shares Down 10%
americanbankingnews.com - April 20 at 3:32 PM
Pharvaris B.V. (NASDAQ:PHVS) Shares Gap Down to $29.59Pharvaris B.V. (NASDAQ:PHVS) Shares Gap Down to $29.59
americanbankingnews.com - April 15 at 1:50 PM
Pharvaris B.V. (NASDAQ:PHVS) Sees Large Volume IncreasePharvaris B.V. (NASDAQ:PHVS) Sees Large Volume Increase
americanbankingnews.com - April 12 at 11:33 AM
Pharvaris B.V. (NASDAQ:PHVS) Trading Up 5.9%Pharvaris B.V. (NASDAQ:PHVS) Trading Up 5.9%
americanbankingnews.com - April 8 at 11:50 AM
Pharvaris B.V. (NASDAQ:PHVS) Trading Up 7.7%Pharvaris B.V. (NASDAQ:PHVS) Trading Up 7.7%
americanbankingnews.com - April 1 at 11:36 AM
Pharvaris B.V. (NASDAQ:PHVS) Shares Gap Up to $26.23Pharvaris B.V. (NASDAQ:PHVS) Shares Gap Up to $26.23
americanbankingnews.com - March 29 at 11:48 AM
Pharvaris Announces Closing of Initial Public OfferingPharvaris Announces Closing of Initial Public Offering
finance.yahoo.com - March 9 at 9:33 AM
Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual MeetingPharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting
finance.yahoo.com - March 9 at 9:33 AM
Pharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study Evaluating PHVS416 for the On-Demand Treatment of HAEPharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study Evaluating PHVS416 for the On-Demand Treatment of HAE
finance.yahoo.com - March 9 at 9:33 AM
Pharvaris to Participate in BioCapital EuropePharvaris to Participate in BioCapital Europe
finance.yahoo.com - March 9 at 9:33 AM
This page was last updated on 4/21/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.